Internal Medicine, Gastroenterology · Littleton, CO
NPI
1205822707
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1001 Southpark Dr
Littleton, CO, 80120
Phone (303) 722-8987
Groups this clinician bills Medicare through
Medicare paid, 2024
$83K
2,136 services
Medicare patients, 2024
283
Average age 74
Drug cost, 2024
$2.0M
891 prescriptions
Company payments, 2025
$1,396
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Luke T Evans was code 45385 (colonoscopy - lesion removal), 91 times for 89 patients. In total Luke T Evans billed 2,136 services in 58 codes, and Medicare paid $83K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-04-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 45385 Colonoscopy - Lesion Removal | Facility | 91 | 89 | $193.38 | $18K |
| 99214 Office E&M - Established | Office | 55 | 46 | $79.31 | $4,362 |
| 43239 Upper GI Endoscopy | Facility | 55 | 52 | $61.27 | $3,370 |
| 45380 Lower GI Endoscopy - Other | Facility | 28 | 28 | $57.91 | $1,621 |
| 99232 Hospital E&M - Subsequent | Facility | 26 | 21 | $59.59 | $1,549 |
| 99222 Hospital E&M - Initial | Facility | 23 | 22 | $98.75 | $2,271 |
| 99213 Office E&M - Established | Office | 21 | 20 | $59.37 | $1,247 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 20 | 20 | $173.43 | $3,469 |
| 99204 Office E&M - New | Office | 14 | 14 | $113.84 | $1,594 |
| 43249 Upper GI Endoscopy | Facility | 11 | 11 | $94.76 | $1,042 |
| 43248 Upper GI Endoscopy | Facility | 11 | 11 | $94.72 | $1,042 |
By year: 2022 $65K for 1,651 services; 2023 $66K for 1,165 services; 2024 $83K for 2,136 services.
Medicare prescription drug claims, 2024
In 2024, the drug Luke T Evans prescribed most often to Medicare patients was Omeprazole, with 222 prescriptions and refills. In total Luke T Evans wrote 891 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 222 | 487 | 73 | $4,255 |
| Pantoprazole Sodium Generic | 141 | 339 | 43 | $1,470 |
| Stelara Ustekinumab | 46 | 61 | Under 11 | $1.3M |
| Kcl-D5w-0.45% Nacl Potassium Chloride/D5-0.45nacl | 40 | 40 | Under 11 | $1,380 |
| Esomeprazole Magnesium Generic | 35 | 59 | 11 | $1,283 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 29 | 29 | 27 | $526 |
| Humira Pen Adalimumab | 25 | 25 | Under 11 | $268K |
| Mesalamine Generic | 25 | 25 | Under 11 | $2,767 |
| Famotidine Generic | 21 | 54 | Under 11 | $388 |
| Viberzi Eluxadoline | 16 | 22 | Under 11 | $35K |
| Dexlansoprazole Dr Dexlansoprazole | 15 | 44 | Under 11 | $5,934 |
| Creon Lipase/Protease/Amylase | 13 | 23 | Under 11 | $71K |
| Dicyclomine Hcl Generic | 11 | 29 | Under 11 | $426 |
| Budesonide Dr Budesonide | 11 | 12 | Under 11 | $1,929 |
| Xifaxan Rifaximin | 11 | 11 | Under 11 | $35K |
Brand drugs: 228 claims; generic drugs: 663 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Luke T Evans $1,396 ($1,396 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $318.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 20 | $318 |
| Madrigal Pharmaceuticals MDGL | 5 | $156 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $136 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 5 | $107 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 4 | $87.42 |
| Pfizer Inc. PFE | 5 | $86.92 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $80.83 |
| Genzyme Corporation SNY | 4 | $79.56 |
| Gilead Sciences, Inc. GILD | 3 | $73.98 |
| Janssen Biotech, Inc. JNJ | 2 | $55.17 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.